EPIDEMIOLOGY

SGLT2 inhibitor-associated DKA affects less than 1% of all patients, with the majority of cases occurring soon after initiation of the medication—could this outcome be related to genetic factors? The DaNGER study aims to answer this question. Contact us if you want to join our growing network.

More Info

The Coronavirus in the Urban Built Environment (CUBE) project aims to develop environmental surface sampling (specifically, of floors) as a spatially-resolved method for early detection and monitoring of COVID-19 in congregate settings like long-term care homes, universities, public schools, and daycares.

More Info

The Evaluating risks and benefits of Newer Diabetes medications when Used in Routine care (ENDURE) project is an observational cohort study assessing the use of SGLT2s and GLP1s in hospitals to better understand factors related to the decision to either prescribe or not prescribe an SGLT2 or GLP1, the risk of DKA when a hospitalized patient is given an SGLT2, and the short- and long-term consequences when a patient who may benefit from an SGLT2 or GLP1 does not receive one.

GEMINI is the largest network for healthcare data and analytics in Canada, designed to collect detailed clinical patient data and hospital data, which can then be used by researchers in a confidential yet accessible manner. Our lab helped to develop GEMINI DM, a subset of the database that serves as a repository for information on patients living with diabetes.